The biggest cloud hanging over Alex Azar during his Senate confirmation hearing Wednesday was his pharmaceutical industry background. Republicans praised the experience as an advantage to tackle high drug costs, while Democrats said it raises conflicts of interest and encourages a revolving door mentality. Azar’s response: He will not “implement pharma’s policy agenda. I don’t … Continue reading Vitals